VisMederi’s diagnostic testing division is focused upon the evaluation of new drugs using in vitro tests with the objective of providing a wider range of services in addition to vaccines studies and research.

This area of advanced research services has been recently implemented focusing in particular on the performance of immuno-enzymatic tests for the detection of antigens, proteins or other detectable substances found in biological substrates (e.g. the detection of meningococcal surface antigens).